Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease.
- DOI
- 10.3389/fimmu.2021.694457
- Published
- 2021
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2021.694457,
title = {Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease.},
author = {Nakagawa T and Sanchez-Lozada LG and Andres-Hernando A and Kojima H and Kasahara M and Rodriguez-Iturbe B and Bjornstad P and Lanaspa MA and Johnson RJ},
year = {2021},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2021.694457},
url = {https://doi.org/10.3389/fimmu.2021.694457}
}RIS
TY - JOUR TI - Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease. AU - Nakagawa T AU - Sanchez-Lozada LG AU - Andres-Hernando A AU - Kojima H AU - Kasahara M AU - Rodriguez-Iturbe B AU - Bjornstad P AU - Lanaspa MA AU - Johnson RJ PY - 2021 JO - Frontiers in immunology DO - 10.3389/fimmu.2021.694457 UR - https://doi.org/10.3389/fimmu.2021.694457 ER -
APA
T, N., LG, S., A, A., H, K., M, K., B, R., P, B., MA, L., & RJ, J. (2021). Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2021.694457
Source records
- pubmed · retrieved 2026-09-26T21:01:41.794Z